|
⚲
|
| Keyboard |
| Declan Doogan | |
|---|---|
| Firm | |
| Address | c/o Tenax Therapeutics, Inc 101 Glen Lennox Drive, Ste 300 Chapel Hill, NC 27517 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Tenax Therapeutics Inc | 021-522335 | Director | 99.7 M of 175.0 M |
||
| Causeway Therapeutics Ltd | 021-474432 | Director | 14.3 M of 14.3 M |
||
| Tenax Therapeutics Inc | 021-447764 | Director | 8.0 M of 8.0 M |
||
| Juvenescence Ltd | 021-385098 | Executive Officer | 9.4 M | ||
| Juvenescence Ltd | 021-365288 | Executive Officer | 56.9 M of 80.0 M |
||
| KLEO Pharmaceuticals Inc | 021-330541 | Director | 21.2 M of 21.2 M |
||
| Juvenescence Ltd | 021-316203 | Director | 53.1 M of 53.1 M |
||
| Juvenescence Ltd | 021-300223 | Director | 2.5 M of 3.0 M |
||
| KLEO Pharmaceuticals Inc | 021-287320 | Director | 13.5 M | ||
| Biohaven Pharmaceutical Holding Co Ltd | 021-274252 | Director | 40.0 M of 80.0 M |
||
| Spinifex Pharmaceuticals Inc | 021-216941 | Director | 6.2 M of 16.0 M |
||
| Trojan Technologies USA LLC | 021-146010 | Director | of 0.3 M |
||